SCHEMBL28846321

SCHEMBL28846321

COc1ccccc1C(=O)Nc1ccc(S(=O)(=O)N2CCCCC2)s1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.65
▸ MEN1 O00255 6/20 0.65
▸ MAPT P10636 5/20 0.65
▸ TP53 P04637 2/20 0.65
▸ THRB P10828 1/20 0.65
▸ ALDH1A1 P00352 5/20 0.63
▸ POLB P06746 1/20 0.63
▸ ATM Q13315 1/20 0.60
▸ RXFP1 Q9HBX9 2/20 0.56
▸ UBE2N P61088 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ AHR P35869 1/20 0.52
▸ GFER P55789 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ LMNA P02545 2/20 0.52
▸ HPGD P15428 2/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156741 0.89 MAPT (0.57) KMT2AMEN1MAPTTP53THRB
SCHEMBL28156720 0.84 MAPT (0.64) KMT2AMEN1MAPTTP53ALDH1A1
SCHEMBL16246327 0.81 CFTR (0.60) KMT2AMEN1MAPTTP53THRB
SCHEMBL28953644 0.80 ALDH1A1 (0.64) KMT2AMEN1MAPTTP53ALDH1A1
SCHEMBL28157304 0.79 KMT2A (0.66) KMT2AMEN1MAPTTP53THRB
SCHEMBL28157289 0.76 MAPT (0.61) KMT2AMEN1MAPTTP53THRB
SCHEMBL28157272 0.74 LMNA (0.51) KMT2AMEN1MAPTTP53THRB
SCHEMBL28157411 0.73 KDM1A (0.55) KMT2AMEN1MAPTALDH1A1POLB
SCHEMBL28157299 0.73 MAPT (0.66) KMT2AMEN1MAPTTP53ALDH1A1
SCHEMBL28157274 0.72 KAT6A (0.57) KMT2AMEN1MAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback